Aptevo Therapeutics (APVO) stock forecast for 2022 – 2027

Are you interested in Aptevo Therapeutics Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the APVO stock price in 2022-2027. Is APVO a good long term stock? When should I take profit in Aptevo Therapeutics stock? Buy or sell stock? Will APVO stock price go up? What are analysts’ forecasts for APVO stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. APVO stock returns are also predicted based on historical data.

According to our research, APVO stock is a awesome long-term investment. APVO share price has been in a bull cycle for the past year. Aptevo Therapeutics Inc. stock trend is positive.

Aptevo Therapeutics company info

Industry Biotechnology
Address 2401 4th Avenue, Seattle, WA, 98121, United States
Website https://www.aptevotherapeutics.com

Forecasting

52 Week High: 14.4733 USD
52 Week Low: 6.04586 USD
1 Year Forecast: 12.58 USD
5 Year Forecast: 43.5997 USD

Agilent Technologies info

Market Cap: 28.21M
52 Week Change: -28.981%
52 Week High: 43.21 USD
52 Week Low: 4.74 USD
Beta: 0.73307
50 Day Moving Average: 7.2
90 Day Moving Average: 8.810
200 Day Moving Average: 13.42
Resistance Level: 5.90886
Pivot Point: 5.88234
Support Level: 5.84766
Enterprise Value: 3,361,510
Forward P/E: -1.28
Forward EPS: -4.23
Profit Margin: -265.80%
Shares Outstanding: 4,898,030
EBITDA: -0.15
Held Percent Institutions: 21.07%
PEG Ratio (5Y): 0
Trailing EPS: -6.6

Aptevo Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Aptevo Therapeutics Stock Forecast for 2022

March 2022 7.92 7.14 -9.85%
April 2022 7 7.92 13.14%
May 2022 8 7.92 -1%
June 2022 9 9.18 2%
July 2022 8.16 9.09 11.4%
August 2022 8.91 9.09 2.02%
September 2022 9 8 -11.11%
October 2022 8.91 9.09 2.02%
November 2022 9.18 14.28 55.56%
December 2022 14 12.24 -12.57%

Aptevo Therapeutics Stock Forecast for 2023

January 2023 11.76 15 27.55%
February 2023 16.32 16 -1.96%
March 2023 16.32 15.3 -6.25%
April 2023 15.3 15.3 0%
May 2023 16.16 15.84 -1.98%
June 2023 16 15.68 -2%
July 2023 15.84 15.84 0%
August 2023 17 17.34 2%
September 2023 15.68 16.16 3.06%
October 2023 15.84 17 7.32%
November 2023 16.83 21.78 29.41%
December 2023 22.44 20.2 -9.98%

Aptevo Therapeutics Stock Forecast for 2024

January 2024 20.2 22.54 11.58%
February 2024 23.23 23.46 0.99%
March 2024 23 22.54 -2%
April 2024 23 24.48 6.43%
May 2024 23.76 23.52 -1.01%
June 2024 23.76 23.76 0%
July 2024 23.76 24.24 2.02%
August 2024 24.24 24.24 0%
September 2024 24 23.76 -1%
October 2024 24.24 25.5 5.2%
November 2024 25.5 29.4 15.29%
December 2024 30.3 28.28 -6.67%

Aptevo Therapeutics Stock Forecast for 2025

January 2025 28 31.31 11.82%
February 2025 31.36 30.69 -2.14%
March 2025 30.38 31 2.04%
April 2025 31.31 30.69 -1.98%
May 2025 31.62 31.36 -0.82%
June 2025 32.32 32.64 0.99%
July 2025 32.64 32.64 0%
August 2025 32 32.64 2%
September 2025 31.36 31.36 0%
October 2025 32.32 32.67 1.08%
November 2025 34.34 37.62 9.55%
December 2025 37.62 36 -4.31%

Aptevo Therapeutics Stock Forecast for 2026

January 2026 35.64 39.78 11.62%
February 2026 39.78 39.39 -0.98%
March 2026 38.22 38.22 0%
April 2026 39.39 38.22 -2.97%
May 2026 39.39 39.6 0.53%
June 2026 39.2 40 2.04%
July 2026 40.4 40.8 0.99%
August 2026 40.4 40.8 0.99%
September 2026 39.6 40.4 2.02%
October 2026 40.4 39.6 -1.98%
November 2026 41 46.92 14.44%
December 2026 46.46 43.12 -7.19%

Aptevo Therapeutics Stock Forecast for 2027

January 2027 43.12 44.1 2.27%